Company / Total Assets
PALVELLA THERAPEUTICS, INC. Total Assets History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$88.2M
FY2024
5-year range
$7.5M / $153.6M
FY2020-FY2024
Trend
+1069.0%
vs FY2023
Sector context
#209 of 214
Health Care
What the data says
Total Assets changed +1069% YoY in FY2024, a notable deviation from the 9-year average annual change of +133%.
Based on SEC 10-K filings.
$88M in FY2024 with a 5-year CAGR of -9.0%.
Declined from $95M to $88M over the past 2 years.
Health Care sector context is included.
Total Assets over time
Growth rates
- 3-Year CAGR
- -16.9%
- 5-Year CAGR
- -9.0%
- 10-Year CAGR
- -
Sector benchmark
Bottom 2% in Health CareTop 98% of 214This company $88.2M Sector average $7.5B
▼
-98.8% below sector average
Key checks
Key Insights
- 5-year CAGR of -9.0%, indicating a declining trend.
- In FY2024, total assets increased 1069.0% year-over-year.
- Ranks #209 out of 214 companies in the Health Care sector.
- Peak total assets was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score 1.15 (distress zone, below 1.8 threshold)
- Strong profit margin: 43.7%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $88.2M | +1069.0% |
| FY2023 | $7.5M | -92.1% |
| FY2022 | $95.5M | -37.8% |
| FY2021 | $153.6M | +46.2% |
| FY2020 | $105.0M | -25.6% |
| FY2019 | $141.1M | -0.2% |
| FY2018 | $141.3M | +36.1% |
| FY2017 | $103.9M | +196.3% |
| FY2016 | $35.1M | +3.3% |
| FY2015 | $34.0M | +55.3% |
As of FY2024 · SEC 10-K Annual Filings · Updated Jun 30, 2026